Keenan
ValenzaBio, Inc.
2
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
William A Gahl, M.D.
National Human Genome Research Institute (NHGRI)
Shared therapeutic areas:
ALFONS SEGARRA, MD, PhD
Hospital Universitari Vall d´Hebron, Barcelona. Spain
Shared therapeutic areas:
JORGE ROJAS, MD
IIS Fundación Jiménez Díaz, Madrid. Spain
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
RIVERA FRANCISCO, MD
Hospital de Ciudad Real. Spain
Shared therapeutic areas:
GALEANO CRISTINA, MD
Hospital Universitario Ramón y Cajal, Madrid. Spain
Shared therapeutic areas:
RODRIGUEZ ANTOLINA, MD
Hospital Clínico San Carlos, Madrid. Spain
Shared therapeutic areas:
VIRGINIA CABELLO, MD
Hospital Virgen del Rocío, Sevilla. Spain
Shared therapeutic areas:
QUINTANA LUIS, MD
Hospital Clinic de Barcelona. Spain
Shared therapeutic areas:
CAO MERCEDES, MD
Hospital Universitario de A Coruña. Spain
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)
Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy
All 2 trials loaded